Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism. (Q50547983)
Jump to navigation
Jump to search
scientific article published on 28 March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism. |
scientific article published on 28 March 2011 |
Statements
Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism (English)
Agnieszka Jazwa
Nadia G Innamorato
Marlen Hesse
Javier Fernández-Ruiz
28 March 2011